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	 Preparation	 of	 quinolinyl‐3‐oxopropanoic	 acid	 was	 accomplished	 by	 hydrolysis	 of
pyranoquinolinedione,	in	aqueous	alkaline	medium.	The	chemical	behavior	of	this	β‐keto	acid
towards	 nitrosation,	 coupling	 with	 a	 diazonium	 salt,	 esterification,	 condensation	 with	 2,2‐
diethoxyethanamine,	hydrazinolysis,	Knoevenagel	condensation	with	isatine,	salicylaldehyde,
3‐formylquinolones,	 and	3‐formylchromone,	was	 investigated.	Also	many	of	 the	products	of
these	 reactions	were	obtained	 using	 either	pyranoquinolinedione	1	 or	 β‐keto	 acid	2,	 under
the	same	conditions.	
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1.	Introduction	
	
In	 the	 recent	years,	an	 increasing	 interest	 in	 the	synthesis	
of	 functionalized	 4‐hydroxyquinolin‐2(1H)‐ones,	 with	
important	 biological	 properties	 has	 been	 observed.	 A	 broad	
number	 of	 important	 pharmacological	 activities	 have	 been	
associated	 with	 3‐substituted	 4‐hydroxyquinolin‐2(1H)‐ones	
[1‐5].	Many	 derivatives	 of	 this	 biologically	 active	 heterocyclic	
category	are	naturally	occurring	compounds,	which	were	found	
as	 useful	 intermediates	 for	many	medicinal	 products	 [6‐8].	 It	
had	 been	 reported	 that	 N‐methyl	 derivatives	 of	 4‐
hydroxyquinolin‐2(1H)‐one	 are	 associated	 with	 significant	
biological	 activity	 [9‐11],	 and	 many	 derivatives	 of	 6‐
methylpyrano[3,2‐c]quinolinone	are	known	as	pharmaceutical	
active	ingredients,	e.g.	the	well‐known	alkaloids:	veprisines	and	
flindersines	 [12,13].	 Pyrano[3,2‐c]quinolinones	 were	 found	 to	
be	 active	 against	 certain	 immuno‐reaction	 diseases,	 in	
particular	 against	 immediate	 hypersensitivity	 reactions	
(anaphylaxis).	 Furthermore,	 they	 were	 distinguished	 by	 a	
strong	 systemic	 antiallergic	 action	 and	 therefore,	 they	 are	
suitable	 for	 the	 treatment	 and	 the	 prophylaxis	 of	 allergy	
diseases	 [14].	 In	 general,	 most	 of	 these	 medicines	 include	 4‐
oxyquinolin‐2‐one	 as	 the	 stem	 heterocyclic	 system.	 Thus,	 the	
majority	of	the	viable	syntheses	of	this	category	of	compounds	
employed	 the	 cyclization	 of	 the	 corresponding	 4‐
hydroxyquinolin‐2(1H)‐ones.	In	turn	these	pyranoquinolinones	
were	 used	 on	wide	 range	 to	 obtain	 4‐hydroxyquinolin‐2(1H)‐
one	 and	 3‐acetyl‐4‐hydroxyquinolin‐2(1H)‐one	 derivatives	
[15].	 So	 that	 4‐hydroxypyrano[3,2‐c]quinoline‐2,5(6H)‐diones	
are	very	important	synthons	to	obtain	several	3‐substituted	4‐
hydroxyquinolin‐2(1H)‐ones	 especially	 3‐acyl	 derivatives	
[16,17].	 Recently,	 Razzaq	 et	 al.	 [18]	 had	 described	 a	 rapid	
preparation	of	pyranoquinolinone	1	using	microwave	assisted	
conditions.	 Earlier,	 Bowman	 et	 al.	 [19]	 had	 reported	 one	 pot	
synthesis	 of	 4‐hydroxypyrano[3,2‐c]quinoline‐2,5(6H)‐diones	
by	condensation	of	the	appropriate	aniline	with	excess	diethyl	
malonate,	 a	 technique	 which	 is	 still	 the	 most	 successful	
procedure	to	obtain	such	heterocyclic	system	and	we	apply	to	
this	 methodology	 in	 order	 to	 prepare	 our	 starting	 material;	
pyranoquinolinone	 1.	 In	 connection	 to	 our	 program	 work	
which	 deals	with	 substituted	 quinolinones,	 our	 attention	was	
directed	 to	 obtain	 new	 multi‐functionalized	 quinolinone	
derivatives	 of	 expected	 biological	 activity	 especially	 as	
antimalarial	 and	 antiparasitic	 [1,2].	 In	 the	 present	 work,	 we	
describe	 the	 synthetic	 utility	 of	 pyranoquinolinone	 1	 and	 its	
alkaline	 hydrolysis	product;	 3‐(4‐hydroxy‐1‐methyl‐2‐oxo‐1,2‐
dihydroquinolin‐3‐yl)‐3‐oxopropanoic	 acid,	 2,	 to	 obtain	 new	
heterocyclic	 derivatives	 incorporating	 quinoline‐2‐one	moiety	
of	expected	antiparasitic	activity.	
	
2.	Experimental	
	
2.1.	General	
	
Melting	points	are	uncorrected	and	were	determined	on	a	
digital	 Stuart‐SMP3	 apparatus.	 IR	 spectra	 were	 taken	 on	 a	
Perkin‐Elmer	 FT‐IR	 1650	 in	 KBr	 disks.	 1H	NMR	 spectra	were	
recorded	on	Varian	Gemini‐200	NMR‐spectrometer	(200	MHz),	
using	 DMSO‐d6	 or	 CDCl3	 as	 solvents	 and	 TMS	 as	 internal	
reference.	Mass	 spectra	were	 determined	 on	 a	 Shimadzu	 GC‐
MS‐QP	1000	EX	mass	spectrometer	at	70	eV.		
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Scheme	1
	
	
Elemental	 microanalyses	 were	 performed	 on	 a	 Perkin	 Elmer	
CHN‐2400	Analyzer.	All	reactions	were	monitored	by	thin‐layer	
chromatography	 (TLC)	 on	 0.2‐mm	 silica	 gel	 F‐254	 (Merck)	
plates,	 using	 UV	 light	 (254	 and	 366	 nm)	 for	 detection.	
Authentic	 samples	 of	 compounds	1	 [20],	3b	 [21],	9	 [16],	14a	
[22],	14b	[23],	18	[24]	and	21	[25]	were	prepared	according	to	
the	literature	methods.	
	
2.2.	4‐Hydroxy‐6‐methylpyrano[3,2‐c]quinoline‐2,5(6H)‐
dione	(1)	
	
2.2.1.	Procedure	A	
	
The	‐keto	acid	2	(1.3	g,	5	mmol)	was	portion‐wise	added	
to	concentrated	sulfuric	acid	(10	mL)	with	continuous	stirring	
where	the	internal	temperature	was	kept	60‐65	oC	by	means	of	
thermostated	 water‐bath.	 After	 completion	 of	 addition	 the	
mixture	was	stirred	at	 the	ambient	 temperature	 for	2	hr,	 and	
then	poured	onto	crushed	ice	to	give	a	brown	precipitate.	The	
precipitate	 so	 formed	was	 filtered,	 washed	with	 cold	 ethanol	
and	crystallized	to	give	the	pyranoquinolinone,	1	[20]	(Scheme	
1)	(Table	1	and	2).	
	
2.2.2.	Procedure	B	
	
A	 solution	 of	 the	 ester	 derivative	3a	 (0.29	 g,	 1	mmol),	 in	
DMF	 (10	 mL),	 was	 heated	 under	 reflux	 for	 4	 h.	 Then,	 the	
reaction	mixture	was	left	to	cool,	at	room	temperature,	and	the	
crystalline	precipitate	so	formed	was	filtered	and	recrystallized	
to	give	the	pyranoquinolinone,	1.	
	
2.3.	3‐(4‐Hydroxy‐1‐methyl‐2‐oxo‐1,2‐dihydroquinolin‐3‐yl)‐
3‐oxopropanoic	acid	(2)	
	
The	compound	1	(2.43	g,	10	mmol)	was	dissolve	in	sodium	
hydroxide	solution	(20	mL,	2M)	and	warmed	at	~	50	oC	for	30	
min,	 and	 then	 the	 solution	 so	 obtained	 was	 filtered	 off.	 The	
clear	solution	was	precipitated	by	dilute	hydrochloric	acid.	The	
precipitate	 was	 filtered,	 washed	 with	 water,	 dried	 and	
crystallized	(Scheme	1)	(Table	1	and	2).		
	
2.4.	Methyl	3‐(4‐Hydroxy‐1‐methyl‐2‐oxo‐1,2‐dihydro	
quinolin‐3‐yl)‐3‐oxopropanoate	(3a)	and	Ethyl	3‐(4‐
hydroxy‐1‐methyl‐2‐oxo‐1,2‐dihydroquinolin‐3‐yl)‐3‐oxo	
propanoate	(3b)	
	
To	a	 suspension	of	 the	 compound	2	 (2.61	g,	 10	mmol),	 in	
the	proper	 alcohol	 viz;	 absolute	methanol	 and/or	 ethanol	 (20	
mL),	concentration	sulfuric	acid	(5	mL)	was	added	and	stirred	
up	 at	 room	 temperature	 overnight.	 The	precipitate	 so	 formed	
was	filtered,	washed	with	water,	dried,	and	crystallized	to	give	
the	esters	3a	and	3b	[21]	(Scheme	1)	(Table	1	and	2).		
	
2.5.	3‐(4‐Hydroxy‐1‐methyl‐2‐oxo‐1,2‐dihydroquinolin‐3‐yl)‐
2‐oximo‐3‐oxopropanoic	Acid	(4)		
	
To	a	previously	cooled	solution	(0‐5	oC)	of	the	‐keto	acid	2	
(1.3	 g,	 5	mmol),	 in	 aqueous	 sodium	 carbonate	 (50	mL,	 1	M),	
was	 drop‐wise	 added	 nitrous	 acid	 (freshly	 prepared	 from	
solution	 of	 sodium	nitrate	 (0.35	 g,	 5	mmol)	 in	 ice‐cold	water	
(10	mL),	 and	hydrochloric	acid	 (60	mL,	1	M)	with	continuous	
stirring	for	about	30	min.		
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Scheme	2
		
	
After	completion	of	addition	at,	 the	mixture	was	stirred	at	
the	 ambient	 temperature.	 The	 bright	 orange	 precipitate	 that	
formed	 was	 filtered,	 washed	 several	 times	 with	 cold	 water,	
dried	and	crystallized	to	give	the	oxime	4	(Scheme	2)	(Table	1	
and	2).		
	
2.6.	6‐Methyl‐3‐oximopyrano[3,2‐c]quinoline‐2,4,5(3H,6H)‐
trione	(5)	
	
2.6.1.	Procedure	A	
	
The	compound	4	(0.58	g,	2	mmol)	was	portion‐wise	added	
to	 concentrated	 sulfuric	 acid	 (5	 mL)	 and	 stirred	 at	 room	
temperature	 for	 2	 hr.	 The	 dark	 brick	 red	 solution	 so	 formed	
was	 poured	 onto	 crushed	 ice.	 The	 separated	 deep	 orange	
deposits	 were	 filtered,	 washed	 with	 cold	 water	 several	 time,	
dried	 and	 crystallized	 to	 give	 the	 oximopyranoquinoline	 5	
(Scheme	2)	(Table	1	and	2).	
	
2.6.2.	Procedure	B	
	
To	 a	 previously	 cooled	 solution	 (0‐5	 oC)	 the	 compound	1	
(1.22	 g,	 5	mmol),	 in	 aqueous	 sodium	 carbonate	 (50	mL,	 1M),	
was	 drop‐wise	 added	 nitrous	 acid	 (freshly	 prepared	 from	
solution	 of	 sodium	nitrate	 (0.35	 g,	 5	mmol)	 in	 ice‐cold	water	
(10	mL),	 and	hydrochloric	acid	 (60	mL,	1	M)	with	continuous	
stirring	 for	 about	30	min.	After	 completion	of	 addition	at,	 the	
mixture	was	stirred	at	the	ambient	temperature.		
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Table	1.	Analytical	data	of	the	new	compounds.	
Compound		
No.	
Yield,		
% 
M.p.,	oC	
Crystallization	solvent 
Formula	
M.wt.,	g	
Analysis	Calculated/Found	
C% H%	 N%
1	 90a	
76b	
255‐257c	
Dioxane	
C13H9NO4	
243.22	
64.20	
64.00	
3.73	
3.70	
05.76	
05.60	
2	 94	 225‐227	
DMF	
C13H11NO5
261.24	
59.77
59.80	
4.24	
4.20	
05.36
05.40	
3a	 85	 120‐122	
Dioxane	
C14H13NO5
275.26	
61.09
61.2	0	
4.76	
4.80	
05.09
04.80	
3b	 83	 130‐132d	
Dioxane	
C15H15NO5	
289.29	
62.28	
62.00	
5.23	
5.30	
04.84	
04.80	
4	 70	 244‐245	
CHCl3	
C13H10N2O6	
290.23	
53.80	
53.80	
3.47	
3.50	
09.65	
09.70	
5	 60a	
76b	
190‐191	
DMSO	
C13H8N2O5
272.22	
57.36
57.30	
2.96	
2.90	
10.29
10.00	
6	 67	 250‐252	
EtOH	
C19H14N4O7
410.35	
55.61
55.50	
3.44	
3.30	
13.65
13.40	
7	 81a	
80b	
275‐276	
DMF	
C19H12N4O6	
392.33	
58.17	
58.10	
3.08	
3.10	
14.28	
14.40	
8	 67	 200‐201	
DMF	
C16H14N2O4
298.30	
64.42
64.40	
4.73	
4.60	
09.39
09.20	
9	 56	 284‐285e	
DMSO	
C13H11N3O3
257.25	
60.70
60.5	0	
4.31	
4.40	
16.33
16.00	
10	 75	 >300	
AcOH	
C21H14N2O6
390.36	
64.62
64.50	
3.62	
3.50	
07.18
07.00	
11	 70e	
88f	
>300	
DMF	
C21H12N2O5	
372.34	
67.74	
67.70	
3.25	
3.20	
07.52	
07.50	
12	 90	 290‐292	
DMSO	
C20H13NO5
347.33	
69.16
69.30	
3.77	
3.60	
04.03
03.80	
13	 79f	 >300	
DMF	
C20H13NO5
347.33	
69.16
69.10	
3.77	
3.70	
04.03
04.00	
17a	 74a	
65b	
>300	
AcOH	
C24H16N2O6	
428.40	
67.29	
67.50	
3.76	
3.50	
06.54	
06.40	
17b	 79a	
68f	
>300	
AcOH	
C24H16N2O6	
428.40	
67.29	
67.40	
3.76	
3.60	
06.54	
06.40	
20	 65	 >300	
DMF	
C23H13NO6
399.36	
69.17
69.10	
3.28	
3.00	
03.51
03.40	
21	 13	 224‐226	
DMF	
C22H15NO5
373.37	
70.77
70.60	
4.05	
3.80	
03.75
03.50	
a	Yield	according	to	Procedure	A.	
b	Yield	according	to	Procedure	B.	
c	Literature	[22]	M.p.:	257	oC.	
d	Literature	[21]	M.p.:	132	oC.	
e	Literature	[3]	M.p.:	287‐288	oC.	
	
The	 deep	 orange	 precipitate	 that	 formed	 was	 filtered,	
washed	several	times	with	cold	water,	dried	and	crystallized	to	
give	the	oximopyranoquinoline	5	(Scheme	2)	(Table	1	and	2).		
	
2.7.	3‐(4‐Hydroxy‐1‐methyl‐2‐oxo‐1,2‐dihydroquinolin‐3‐yl)‐
2‐[(4‐nitro‐phenyl)hydrazono]‐3‐oxopropionic	acid	(6)	
	
To	a	previously	cooled	solution	(0‐5	oC)	of	the	‐keto	acid	2	
(1.3	g,	5	mmol,)	in	sodium	carbonate	(50	mL,	1	M),	was	added	a	
solution	of	p‐nitrophenyldiazonium	chloride,	 freshly	prepared	
from	p‐nitroaniline	 (0.7	g,	5	mmol)	 and	hydrochloric	acid	 (60	
mL,	 1	 M),	 with	 continuous	 stirring	 for	 about	 30	 min.	 After	
completion	of	addition,	the	mixture	was	stirred	at	the	ambient	
temperature	 for	 1	 hr.	 The	 shining	 orange	 precipitate	 that	
formed	 was	 filtered,	 washed	 several	 times	 with	 cold	 water,	
dried	 and	 crystallized	 to	 give	 the	 hydrazone	 6	 (Scheme	 2)	
(Table	1	and	2).	
	
2.8.	6‐Methyl‐3‐(4‐nitrophenyl)hydrazonopyrano[3,2‐
c]quinoline‐2,4,5(3H,6H)‐trione	(7)		
	
2.8.1.	Procedure	A	
	
The	compound	6	(0.82	g,	2	mmol)	was	portion‐wise	added	
to	 concentrated	 sulfuric	 acid	 (5	 mL)	 and	 stirred	 at	 room	
temperature	 for	 2	 hr.	 The	 dark	 brick	 red	 solution	 so	 formed	
was	poured	onto	crushed	ice	and	the	separated	reddish‐orange	
deposits	 were	 filtered,	 washed	 with	 cold	 water	 several	 time,	
dried	and	crystallized	to	give	the	hydrazonopyranoquinoline	7	
(Scheme	2)	(Table	1	and	2).	
2.8.2.	Procedure	B	
	
To	a	previously	cooled	solution	(0‐5	oC)	of	the	compound	1	
(1.22	g,	2	mmol,)	in	sodium	carbonate	(50	mL,	1	M),	was	added	
a	 solution	 of	 p‐nitrophenyldiazonium	 chloride,	 freshly	
prepared	from	p‐nitroaniline	(0.7	g,	5	mmol)	and	hydrochloric	
acid	 (60	mL,	 1	M),	with	continuous	stirring	 for	 about	30	min.	
After	 completion	 of	 addition,	 the	 mixture	 was	 stirred	 at	 the	
ambient	 temperature	 for	1	hr.	 The	 reddish‐orange	precipitate	
that	 formed	was	 filtered,	washed	 twice	with	cold	water,	dried	
and	crystallized	give	the	hydrazonopyranoquinoline	7	(Scheme	
2)	(Table	1	and	2).	
	
2.9.	2‐(4‐Methoxy‐1‐methyl‐2‐oxo‐1,2‐dihydroquinolin‐3‐yl)‐
1H‐pyrrole‐3‐carboxylic	acid	(8)	
	
A	 mixture	 of	 the	 compound	 2	 (0.26	 g,	 1	 mmol)	 and	 2,2‐
diethoxyethanamine	(0.22	mL,	2	mmol),	 in	DMF	(10	mL),	was	
heated	under	reflux	for	6	hr.	Then	the	solvent	was	evaporated	
in	vacuum.	The	residual	semi‐solid	material	was	triturated	with	
cold	ethanol	(5	mL).	The	solid	material	so	formed	was	filtered	
and	crystallized	give	the	pyrrolylquinoline	8	(Scheme	3)	(Table	
1	and	2).	
	
2.10.	4‐Hydroxy‐1‐methyl‐3‐(5‐oxo‐4,5‐dihydro‐1H‐pyrazol‐
3‐yl)quinolin‐2(1H)‐one	(9)	
	
To	 a	 solution	 of	 the	 ‐keto	 acid	 derivative	 30	 (0.52	 g,	 2	
mmol),	in	DMF	(10	mL),	was	added	hydrazine	hydrate	(0.1	mL,		
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2	mmol),	 and	 then	 the	mixture	was	heated	under	 reflux	 for	2	
hr.	The	solid	product,	that	formed,	was	filtered	and	crystallized	
to	give	 the	pyrazolylquinoline	9	 [16]	(Scheme	3)	(Table	1	and	
2).	
	
2.11.	3‐(4‐Hydroxy‐1‐methyl‐2‐oxo‐1,2‐dihydroquinolin‐3‐
yl)‐3‐oxo‐2‐(2‐oxoindolin‐3‐ylidene)propanoic	acid	(10)		
	
A	mixture	of	the	compound	2	(0.26	g,	1	mmol),	isatine	(0.15	
g,	1	mmol),	and	fused	sodium	acetate	(0.5	g,	6	mmol)	in	acetic	
acid	 (20	 mL),	 was	 heated	 under	 reflux	 for	 4	 hr.	 The	 brown	
crystalline	material	so	formed	was	filtered	and	recrystallized	to	
give	the	indoline	derivative	10	(Scheme	4)	(Table	1	and	2).	
	
2.12.	6‐Methyl‐3‐(2‐oxoindolin‐3‐ylidene)‐2H‐pyrano[3,2‐c]	
quinoline‐2,4,5(3H,6H)‐trione	(11)	
	
2.12.1.	Procedure	A	
	
The	 compound	 10	 (0.29	 g,	 1	 mmol)	 was	 portion‐wise	
added	to	concentrated	sulfuric	acid	(5	mL)	and	stirred	at	room	
temperature	 for	 2	hr.	The	dark	 green	 solution	 so	 formed	was	
poured	 onto	 crushed	 ice	 and	 the	 separated	 pale‐yellow	
deposits	 were	 filtered,	 washed	 with	 cold	 water	 several	 time,	
dried	and	crystallized	to	give	the	indoline	11	(Scheme	4)	(Table	
1	and	2).	
	
2.12.2.	Procedure	B	
	
A	 mixture	 of	 the	 compound	 29	 (0.25	 g,	 1	 mmol),	 isatine	
(0.15	g,	1	mmol),	and	fused	sodium	acetate	(0.5	g,	6	mmol)	 in	
acetic	acid	(20	mL),	was	heated	under	reflux	for	4	hr.	The	pale‐
yellow	 crystalline	 material	 so	 formed	 was	 filtered	 and	
recrystallized	to	give	the	 indoline	11	(Scheme	4)	(Table	1	and	
2).	
	
2.13.	4‐Hydroxy‐1‐methyl‐3‐(2‐oxo‐2H‐chromene‐3‐
carbonyl)quinolin‐2(1H)‐one	(12)	
	
A	 mixture	 of	 the	 ‐keto	 acid	 2	 (2.61	 g,	 10	 mmol),	
salicylaldehyde	 (1	mL,	 10	mmol),	 and	 piperidine	 (0.2	mL),	 in	
ethanol	(50	mL),	was	heated	under	reflux	for	4	hrs.	The	pastel‐
yellow	precipitate	so	obtained	was	filtered,	washed	thoroughly	
with	 cold	 ethanol	 and	 crystallized	 to	 give	 the	 coumarin	 12	
(Scheme	4)	(Table	1	and	2).		
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Table	2.	IR	and	1H	NMR	spectral	data	of	the	new	compounds.	
Compound		
No.	
IR	(KBr),		(cm‐1) 1H	NMR	(DMSO‐d6)	†,			 Mass,	m/z	(Ir%)	
2	 3447‐2951	(OH),	
1734	(C=Ocarboxylic),	
1672	(C=Oketone),	
1615	(C=Oquinolone)		
(CDCl3):	3.79	(s,	3H,	NCH3),	3.88	(s,	2H,	CH2),	5.66	
(s,	0.5H,	3‐H),	7.26	(d,	1H,	J	=	8,	8‐H),	7.50	(dd,	1H,	J	
=	7.8,	2.0,	6‐H),	7.80	(dd,	1H,	J	=	7.8,	2.0,	7‐H),	8.32	
(d,	1H,	J	=	8,	5‐H),	13.60	(bs,	0.5H,	OH),	15.60	(bs,	
1H,	OHcarboxylic)	
	
261	(4.1)	(M+̣),	243	(M+̣	‐	H2O)	(22.8),	245	
(3.6),	244	(8.4),	217	(23.3),	215	(100),	216	
(17.6),	131	(32.4),	106	(11.3),	89	(37.3),	76	
(26.3),	65	(22.7),	53	(39.4),	50	(44.2)	
3a	 3444	(OH),	
1735	(C=Oester),	
1672	(C=Oketone),	
1644	(C=Oquinolone),	
1162	(C‐O‐Cether)	
	
3.48	(s,	3H,	NCH3),	3.52	(s,	2H,	CH2),	3.62	(s,	3H,	
OCH3),	7.44	(t,	1H,	J	=	6.2,	6‐	H),	7.64	(d,	1H,	J	=	8,	8‐
H),	7.76	(t,	1H,	J	=	6.2,	7‐H),	8	(d,	1H,	J	=	8,	5‐H),	
13.4	(bs,	1H,	OH)	
275	(4.8)	(M+̣),	276	(1.5),	274(1.9),	261	(9.6),	
245	(18.3),	217	(12.4),	203	(13.8),	175	(100),	
161	(17.6),	145	(24.4),	117	(16.2),	93	(28.1),	
77	(23.2),	64	(16.0),	51	(45.0)	
4	 3446‐	2500	(OH,	NH),	
1739	(C=Ocarboxylic),	
1671	(C=Oketone	+	C=Oquinolone)	
3.50	(s,	3H,	NCH3),	7.52	(	t,	1	H,	J	=	6.4,	C7‐H),	7.79	
(d,	1H,	J	=	8,	C8‐H),	7.90	(t,	1H,	J	=	6.4,C6‐	H),	8	(d,	
1H,	J	=	8,	C5‐H),	12.8	(bs,	1H,	OHoxime),	13.4	(bs,	1H,	
OH),	17.6	(bs,	1H,	OHcarboxylic)	
	
290	(M+̣)	(4.9),	291	(1.3),	285	(15.4),	229	
(5.4),	228	(13.6),	216	(23.0),	215	(40.3),	202	
(18.1),	134	(18.5),	106	(15.7),	77	(75.9),	51	
(100)	
5	 3432	(OH),	
1737	(C=O	pyrone),	
1649	(C=Oquinolone),	
1618	(C=N)	
3.50	(s,	3H,	NCH3),	7.25‐7.32	(t,	J =	6.9	Hz,	1H,	7‐H),
7.45	(d,	J	=	8.0	Hz,	1H,	8‐H),	7.76	(t,	J	=	6.9	Hz,	1H,	
6‐H),	7.98	(d,	J	=	8.0	Hz,	1H,	5‐H),	12.8	(s,	1H,	
OHoxime)	
	
6	 3206‐2434	(OHcarboxylic),	
1737	(C=Ocarboxlic),		
1640	(C=Oquinolone),	
1503,	1481	(NO2)	
	
3.73	(s,	3H,	NCH3),	7.30‐8.05	(m,	8H,	Harom),	9.17	(bs,	
1H,	NH),	12.37	(bs,	1H,	OH),	15.23	(bs,	1H,	
OHcarboxylic)	
410	(M+̣)	(5.1),	411(2.3),	394	(20.4),	365	(10.7),	
349	(17.9),	321	(32.6),	230	(100),	217	(34.7),	
203	(31.8),	175	(56.9)	
7	 3404(NH),		
1725	‐1673	(C=Opyrone),	
1631	(C=O	quinolone),	
1571,	1495	(NO2)	
	
3.73	(s,	3H,	NCH3),	7.33‐8.02	(m,	8H,	Harom),	9.40	(bs,	
1H,	NH)	
392	(M+̣)	(3.6),	393	(1.8),	347	(8.7),	256	(18.0),	
243	(100),	230	(10.4),	217	(40.1),	203	(30.2),	
189	(63.3),	175	(34.2),	161	(32.0)	
8	 3227	(OH,	NH),		
1742	(C=Ocarboxylic),	
1674	(C=Oquinolone)	
3.28	(s,	3H,	NCH3),	3.63	(s,	3H,	OCH3),	6.89	(d,	1H,	J	
=	8.2,	2‐Hpyrrole),	7.09	(d,	1H,	J	=	8.2,	3‐HPyrrole),	7.51	
(t,	1H,	J	=	7.9,	6‐H),	7.82	(m,	2H,	7‐H	+	8‐H),	8.10	(d,	
1H,	J	=	7.8,	5‐H),	9.64	(bs,	1H,	NH),	13.8	(bs,	1H,	
OHcarboxylic)	
	
298	(M+̣)	(15.9),	299	(5.0),	297	(8.4),	283	
(2.9),	269	(8.5),	267	(15.2),	266	(12.0),	254	
(21.2),	215	(20.3),	199	(12.2),	159	(14.5),	131	
(11.0),	77	(21.1),	76	(18.6),	75	(100)	
10	 3429,	3243	(OH,	NH),
1740	(C=Ocarboxylic),	
1730	(C=Oindolone),	
1650	(C=Oquinolone)	
	
3.71	(s,	3H,	NCH3),	6.92‐8.34	(m,	8H,	Harom),	10.42	
(bs,	1H,	NH),	12.40	(bs,	1H,	OH),	14.2	(bs,	1H,	
OHcarboxylic)	
390	(M+̣)	(8.6),	391	(2.6),	346	(34.0),	330	
(22.1),	316	(20.2),	173	(34.6),	159	(43.8),	145	
(32.7)	
11	 3157	(NH),		
1752	(C=Opyrone),		
1652	(C=Oindolone,	C=Oquinolone)	
	
3.52	(s,	3H,	NCH3),	7.04‐8.70	(m,	8H,	Harom),	12.01	
(bs,	1H,	NH)	
372	(M+̣)	(4.6),	373	(1.7),	331	(23.3),	
317(12.5),	255	(100),	241	(10.7),	229	(21.9),	
201	(13.3),	200	(15.2),	173	(18.6),	145	(20.2),	
78	(21.3)	
	
12	 3435	(OH),	
1730	(C=Opyrone),		
1636	(C=O	quinolone)	
	
3.49	(s,	3H,	NCH3),	7.37‐7.84	(s,	8H,	Harom),	8.16	(s,	
1H,	4‐Hcoumarin),	14.80	(bs,1H,	OH)	
347	(M+̣)	(100),	348	(36.0),	349	(6.7),	319	
(39.6),	275	(61.9),	202	(38.4),	173	(57.6),	134	
(46.5),	90	(23.6),	77	(71.4),	63	(46.8)	
	
13	 3423,(OH),		
1670,	1651	(C=Opyrone),	
1644	(C=Oquinolone)	
	
3.52	(s,	3H,	NCH3),	7.15‐7.97	(m,	8H,	Harom),	5.68	(s,	
1H,	Hmethine),	12.00	(bs,	1H,	OH)	
17a	 3415	(OH),		
1717	(C=Opyrone),		
1670	(C=Oquinolone)	
3.70	(s,	3H,	NCH3),	3.77	(s,	3H,	NCH3),	5.82	(s,	1H,	
Hmethine),	7.30‐8.33	(m,	8H,	Harom),	13.4	(bs,	1H,	OH)	
428	(M+̣)	(38.3),	429	(9.4),	400	(31.2),	
399(10.9),	385(6.8),	268(16.4),	254	(29.6),	
226	(8.3),	214	(11.3),	202	(20.4),	199	(60.6),	
172	(14.3),	117	(14.2),	115	(24.0),	104	(38.5),	
77	(100),	76	(29.7),	64	(23.3)	
	
17b	 3438,	3158	(OH),		
1752	(C=Opyrone),		
1657	(C=Oquinolone)	
2.43	(s,	3H,	6CH3),	3.49	(s,	3H,	NCH3),	5.44	(s,	1H,	
Hmethine),	7.31‐8.05	(m,	7H,	Harom),	12.11	(bs,	1H,	
NH),	13.8	(bs,	1H,	OH)	
	
428	(M+̣)	(100),	429	(25.3),	430	(10.6),	427	
(11.3),	400	(74.2),	399	(18.2),	372	(27.3),	226	
(21.4),	200	(25.4),	199	(97.6),	186	(22.6),	39	
(12.8),	104	(55.6),	77	(99.9)	
20	 3051	(C‐Harom),		
1748	(C=Opyrone),		
1644	(C=Opyrone),		
1622	(C=Oquinolone)	
(CDCl3)	3.84	(s,	3H,	NCH3),	6.94	(s,	1H,	Hmethine),	
7.12	(d,	1H,	J	=	7.9,	6‐Hquinolinone),	7.44	‐7.53	(m,	4H,	
Harom),	7.74	(d,	1H,	J	=	8.2,	8‐Hchromone),	8.17	(d,	1H,	J	
=	8.0,	5‐Hquinolone),	8.37	(d,	1H,	J	=	8.2,	5‐Hchromone),	
8.70	(s,	1H,	2‐Hchromone)	
399	(M+̣)	(5.4),	400	(2.2),	398	(25.4),	397	
(100),	396	(35.8),	368	(30.4),	277	(81.6),	276	
(18.3),	104	(11.4),	93	(28.2),	77	(36.2),	65	
(67.2)	
†	All	1H	NMR	experiments	were	carried	out	in	DMSO‐d6	unless	cited.	
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Scheme	4
		
	
2.14.	3‐(2‐Hydroxybenzylidene)‐6‐methylpyrano[3,2‐c]	
quinoline‐2,4,5(3H,6H)‐trione	(13)		
	
A	 mixture	 of	 the	 compound	 1	 (2.43	 g,	 10	 mmol),	
salicylaldehyde	 (1	 mL,	 10	 mmol),	 and	 fused	 sodium	 acetate	
(2.05	 g,	 25	mmol),	 in	 acetic	 acid	 (20	mL),	 was	 heated	 under	
reflux	 for	 4	 hr.	 The	 pale‐yellow	 precipitate	 so	 formed	 was	
filtered,	washed	twice	with	water	and	ethanol,	and	crystallized	
to	give	the	compound	13	(Scheme	4)	(Table	1	and	2).	
	
2.15.	3‐((4‐Hydroxy‐1‐methyl‐2‐oxo‐1,2‐dihydroquinolin‐3‐
yl)methylene)‐6‐methyl‐2H‐pyrano[3,2‐c]quinoline‐2,4,5	
(3H,6H)‐trione	(17a)	and	3‐((4‐Hydroxy‐6‐methyl‐2‐oxo‐1,2‐
dihydroquinolin‐3‐yl)methylene)‐6‐methyl‐2H‐pyrano[3,2‐
c]quinoline‐2,4,5(3H,6H)‐trione	(17b)	
	
A	mixture	of	the	compound	2	(0.52	g,	2	mmol),	the	proper	
aldehyde	derivative	14a	 [22],	14b	[23],	 (0.41	g,	2	mmol),	and	
freshly	fused	sodium	acetate	(0.82	g,	10	mmol),	in	glacial	acetic	
acid	(20	mL)	was	heated	under	reflux	for	4	hr.	The	crystalline	
precipitate	that	formed	was	collected	by	filtration,	washed	with	
cold	 ethanol	 (10	 mL)	 and	 diethyl	 ether	 (10	 mL),	 and	
recrystallized	 to	 give	 the	 corresponding	 pyranoquinoline	17a	
and	17b	(Scheme	5)	(Table	1	and	2). 
	
2.16.	6‐Methyl‐3‐((4‐oxo‐4H‐chromen‐3‐yl)methylene)‐2H‐
pyrano[3,2‐c]quinoline‐2,4,5(3H,6H)‐trione	(20)	and	(E)‐4‐
Hydroxy‐1‐methyl‐3‐(3‐(4‐oxo‐4H‐chromen‐3‐yl)	acryloyl)	
quinolin‐2(1H)‐one	(21)	
	
A	mixture	of	 the	compound	2	 (0.52	g,	2	mmol),	4‐oxo‐4H‐
chromene‐3‐carbaldehyde	 (18)	 [24]	 (0.35	 g,	 2	 mmol),	 and	
freshly	 fused	 sodium	 acetate	 (0.82	 g,	 10	mmol),	 glacial	 acetic	
acid	 (20	mL),	was	 refluxed	 for	5	hr.	The	brown	precipitate	so	
separated	 was	 filtered,	 washed	 with	 cold	 water,	 dried	 and	
crystallized	 from	 hot	 DMF	 (20	 mL)	 to	 give	 reddish‐brown	
prisms	(0.52	g)	of	the	chromenylpyranoquinline	20	(Scheme	5)	
(Table	 1	 and	 2).	 The	 DMF‐mother	 liquor	 filtrate	 of	
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crystallization	was	 evaporated	 to	 about	 one‐third	of	 its	 initial	
volume	 to	 give	 yellowish	 brown	 needles	 (0.10	 g)	 of	 the	
chromenylacryloylquinoline	21	 [25]	 (Scheme	 5)	 (Table	 1	 and	
2).	
	
3.	Results	and	discussion		
	
It	 was	 reported	 that	 boiling	 of	 pyranoquinolinone	 1	 in	
aqueous	 sodium	 hydroxide	 results	 in	 3‐acetyl‐4‐
hydroxyquinolin‐2(1H)‐one	 in	which	 ring‐opening	 is	 followed	
by	 decarboxylation	 [14,26].	 Our	 attempts	 to	 obtain	 a	
quinolinone	bearing	β‐keto	carboxylic	acid	group	at	position‐3	
met	success,	starting	 from	pyranoquinolinone	1.	A	convenient	
facile	basic	hydrolysis	of	pyranoquinolinone	1	was	carried	out	
via	warming	its	aqueous	sodium	hydroxide	solution	at	about	50	
oC,	 to	 give	 3‐(4‐hydroxy‐1‐methyl‐2‐oxo‐1,2‐dihydroquinolin‐
3‐yl)‐3‐oxopropanoic	 acid	 (2)	 in	 94	%	 yield	 (Scheme	 1).	 The	
structure	 of	 the	 product	 was	 established	 on	 basis	 of	 the	
following	analytical	and	spectral	results;	satisfactory	elemental	
microanalysis	for	C,	H,	and	N	elements	is	within	±0.2	%	(Table	
1),	IR	spectrum	revealed	the	presence	of	absorption	bands	at		
3447	and	1734	cm‐1	due	to	CO2H	group,	 1H	NMR	spectrum,	 in	
dimethylsulfoxide	 (DMSO‐d6),	 showed	 that	 it	 exists	 as	 4‐
hydroxyquinolin‐2‐one	 form,	 while	 in	 chloroform	 (CDCl3)	 it	
exists	 as	 2,4‐quinolinedione	 form.	 In	 CDCl3	 the	 proton	 at	
position‐3	 was	 observed	 at	 	 	 5.66	 (Table	 2),	 and	 mass	
spectrum	presented	molecular	 ion	 peak	M+	 at	m/z	 261	 and	 a	
peak	 at	 m/z	 243	 due	 to	 (M‐H2O)+	 ion	 of	 a	 recyclized	
pyranoquinoline	fragment	(Table	2).	
Alkyl	3‐(quinolinyl)‐3‐oxopropanoates	3a,b	were	obtained	
via	 esterification	 of	 the	 ‐keto	 acid	 2	 with	 alcohols	 viz;	
methanol	 and	 ethanol,	 in	 presence	 of	 concentrated	 sulfuric	
acid,	 in	 84	 ±	 1	 %	 yields	 (Scheme	 1).	 1H	 NMR	 spectrum	 of	
compound	3a	(R	=	Et)	showed	signals	at		3.48	due	to	(NCH3),	
3.52	 due	 to	 (‐CH2CO2Me),	 and	 3.62	 due	 to	 (CO2CH3).	 An	
alternative	route	to	obtain	the	ester	3b	(R	=	Et)	was	described	
via	 Claisen	 condensation	 reaction	 between	 diethyl	 carbonate	
and	 3‐acetyl‐4‐hydroxy‐1‐methylquinolin‐2(1H)‐one	 [21].	
However,	 the	 present	 preparation	 from	 compound	 2	 is	
convenient	and	advantageous	because	Claisen	condensation,	in	
which	 many	 by‐products	 are	 formed	 and	 purification	 of	 the	
product	 is	 inconvenient,	 with	 overall	 yield	 ~44	 %,	 starting	
from	 pyranoquinoline	 1,	 a	 nearly	 half	 of	 the	 present	
preparation	yield	[17].	
Nitrosation	 of	 the	 β‐keto	 acid	2,	 using	 sodium	nitrite	 and	
dilute	hydrochloric	 acid	 at	0‐5	 oC,	 furnished	3‐(quinolin‐3‐yl)‐
2‐oximo‐3‐oxopropannoic	acid	4.	As	depicted	in	Scheme	2,	the	
oxime	4	may	exist	in	two	forms;	Z‐form	4	and/or	E‐form	4’.	1H	
NMR	spectrum	of	compound	4	showed	three	signals	at		12.8,	
13.4,	 and	 17.6	 (Table	 2).	 Since	 the	 three	 chemical	 shifts	
disappear	on	deutration,	they	attributed	to	three	OH	groups	of	
oxime,	 quinolinol,	 and	 carboxylic	 acid,	 respectively.	 The	
dehydration	 reaction	 of	 the	 oxime	4,	 in	 concentrated	 sulfuric	
acid,	 is	 expected	 to	 give	 one	 or	 more	 than	 one	 product.	 The	
structures	which	 are	 suggested	 as	 possible	 products	 for	 such	
reaction	 include;	 3‐oximopyrano[3,2‐c]quinolinetrione	 5	 and	
1,2‐oxazino[5,6‐c]quinoline‐3‐carboxylic	 acid,	 (Scheme	 2).	 In	
addition	to	chemical	tests,	 IR	and	1H	NMR	spectral	data	of	the	
product	 showed	 no	 evidences	 for	 presence	 of	 CO2H.	 So	 it	 is	
concluded	that	the	product	of	this	reaction	is	the	compound	5.	
Moreover,	these	results	were	clearly	supported	by	obtaining	of	
the	 pyranoquinoline	 5	 directly	 from	 nitrosation	 of	
pyranoquinoline	1	(Scheme	2).	
The	 coupling	 reaction	 of	 β‐keto	 acid	 2	 with	 p‐
nitrobenzenediazonium	 chloride	 afforded	 an	 orange	 colored	
product.	 IR	 spectrum	 of	 the	 product	 showed	 a	 medium	
absorption	 band	 broaden	 between	 3206‐2434	 cm‐1	 due	 to	 H‐
bonded	 N‐H	 and	 O‐H,	 in	 addition	 to	 two	 strong	 stretching	
bands	at	1737	and	1640	cm‐1	due	to	C=O	of	carboxylic	acid	and	
quinolinone.	1H	NMR	spectrum	revealed	the	presence	of	three	
D‐exchangeable	protons	at		9.17,	12.37,	and	15.23	refer	to	N‐H	
of	 hydrazone	 and	 O‐H	 of	 quinolinol	 and	 carboxylic	 acid.	
Building	on	above	the	structure	of	the	product	was	determined	
as	 3‐quinolinyl‐2‐(4‐nitrophenylhydrazono)‐3‐oxopropionic	
acid	6.	Herein	again	the	Z‐form	6	and	E‐form	6’	are	possible	as	
depicted	in	Scheme	2.	The	structures	of	compounds	4	and	6	as	
seen	need	further	study	using	X‐ray	single	crystal	analysis	but	
unfortunately	we	did	not	succeed	in	getting	suitable	crystals	for	
such	analysis.	
When	the	compound	6	was	subjected	to	dehydration	using	
concentrated	 sulfuric	 acid	 only	 3‐hydrazonopyrano[3,2‐
c]quinolinetrione	 7	 was	 obtained.	 For	 such	 reaction	 one	 can	
also	expect	 to	get	pyridazino[4,3‐c]quinoline‐3‐carboxylic	acid	
by	 the	 possible	 intramolecular	 heterocyclization	 between	
hydrazone	 nitrogen	 and	 quinolinol	 hydroxyl	 group.	 All	
analytical	and	spectral	data	showed	that	carboxylic	group	was	
involved	in	cyclization	and	structure	of	the	product	contains	an	
N‐H	 appeared	 at	 	 9.64	 (exchangeable	 on	 deutration).	
Moreover,	 these	 results	 were	 definitely	 confirmed	 when	 the	
same	hydrazone	derivative	7	was	obtained	via	 coupling	of	the	
pyranoquinolinedione	 1	 with	 p‐nitrobenzenediazonium	
chloride	(Scheme	2).	
The	 reaction	 of	 the	 β‐keto	 acid	 2	 with	 2,2‐
dimethoxyethanamine	 (2‐aminoacetaldehyde	dimethyl	acetal),	
in	 boiling	 DMF,	 was	 carried	 out	 to	 obtain	 a	 2‐(quinolin‐3‐
yl)pyrrole‐3‐carboxylic	 acid	 derivative.	 Unexpectedly,	
characterization	 of	 structure	 of	 the	 product	 using	 elemental	
and	spectral	analyses	indicated	the	existence	of	a	methoxy	and	
a	 carboxylic	 acid	 functions.	 Mass	 fragmentation	 pattern	
revealed	peaks	at	m/z	267	due	to	(M	‐	OCH3)+	ion	and	m/z	254	
due	 to	 (M	 ‐	 CO2)+	 ion	 (Table	 2).	 1H	NMR	 spectrum	 showed	 a	
singlet	signal	at		3.63	due	chemical	shift	of	OCH3	in	addition	to	
two	deuterium	replaceable	protons	appeared	at		9.64	and	13.8	
due	to	pyrrole	N‐H	and	carboxylic	O‐H	(Table	2).	As	depicted	in	
scheme	3,	Friedländer	cyclo‐condensation	reaction	took	place,	
giving	 the	 corresponding	 azomethine	 intermediate,	 which	
underwent	 an	 intramolecular	 SN2	 O‐methylation	 of	 4‐
hydroxyquinolin‐2‐one,	accompanied	by	 loss	of	methanol.	The	
presumed	 aldehyde	 intermediate	 underwent	 smooth	
cyclization,	 leading	 to	 2‐(4‐methoxy‐1‐methyl‐2‐oxo‐1,2‐
dihydroquinolin‐3‐yl)‐1H‐pyrrole‐3‐carboxylic	 acid	 (8)	
(Scheme	3).	
As	 illustrated	 in	 scheme	 3,	 when	 the	 ‐keto	 acid	 2	 was	
subjected	to	react	with	hydrazine	hydrate,	 in	boiling	DMF,	the	
pyrazolinylquinoline	9	was	obtained,	in	moderate	yield	(56	%).	
The	 same	 compound	 was	 also	 obtained	 starting	 from	 the	
pyranoquinolinedione	 1	 as	 previously	 described	 by	 us	 [16].	
Even,	 the	reported	preparation	yield	(92%)	 is	higher	 than	the	
present	but	usage	of	‐keto	acid	2	in	preparation	is	mandatory	
for	 estimation	 of	 orientation	 of	 cyclization.	 In	 case	 of	 ‐
hydroxy‐‐pyrone,	the	nucleophilic	attack	starts	at	lactone	C=O	
followed	by	cyclization	with	nucleophilic	replacement	of	the	‐
enol	OH,	while	in	case	of	‐keto	acid	this	attack	should	start	at	
the	‐C=O	followed	by	cyclization	with	cyclo‐condensation	with	
the	 carboxylic	 group.	 Anyhow	 in	 case	 of	 treatment	 with	
hydrazine	 no	 difference	 is	 noticed	 but	 we	 expect	 that	 both	
compounds	 1	 and	 2	 may	 give	 different	 products	 on	 use	 of	
unsymmetrical	 1,2‐binucleophiles	 like	 mono‐substituted	
hydrazine	and	hydroxylamine.	
Treatment	of	the	β‐keto	acid	2	with	isatine	was	carried	out	
under	 Knoevenagel	 reaction	 conditions	 using	 fused	 sodium	
acetate	and	glacial	acetic	acid.	The	product	of	this	reaction	was	
characterized	 as	 3‐quinolinyl‐3‐oxo‐2‐(indol‐3‐ylidene)	
propanoic	acid	10	 (Scheme	4).	Under	 this	acidic	conditions,	 it	
was	 expected	 to	 obtain	 the	 cyclization	 product;	 indolylidene	
pyranoquinoline	11.		
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However,	when	 the	 product	10	was	 consequently	 treated	
with	concentrated	sulfuric	acid,	this	cyclization	took	place	and	
the	 compound	 11	 was	 formed.	 Interestingly,	 when	 the	
pyranoquinoline	 1	 was	 subjected	 to	 react	 with	 isatine,	 in	
presence	 of	 fused	 sodium	 acetate	 and	 glacial	 acetic	 acid,	 the	
same	compound	11	was	afforded,	in	88	%	yield	(Scheme	4).	
Since	 benzopyrones	 are	 well	 thought‐out	 as	 useful	
synthons	 to	 get	diverse	heterocyclic	 derivatives	 through	 ring‐
opening	ring	closure	(RORC)	reactions	[27‐30],	 it	was	planned	
to	obtain	a	new	quinolinone	derivatives	in	which	benzopyrone	
nucleus	was	constructed	as	 substituent	at	position‐3.	Thus,	β‐
keto	 acid	 2	 was	 subjected	 to	 react	 with	 salicylaldehyde,	 in	
presence	 of	 piperidine	 in	 boiling	 ethanol.	 Both	 coumarin	
derivative	 12	 and	 pyranoquinoline	 derivative	 13	 were	
expected	 as	 products	 of	 this	 reaction	 (Scheme	 4).	 For	 such	
reaction	the	plausible	Knoevenagel	condensation	 intermediate	
was	suggested	due	to	the	reactivity	of	methylene	of	the	β‐keto	
acid	 2.	 This	 intermediate	 can	 undergo	 intramolecular	
nucleophilic	 lactonization,	 forming	 either	 coumarin	 derivative	
12	or	pyranoquinoline	derivative	13.		
The	 elemental	 and	 mass	 analyses	 of	 the	 product	 are	 not	
differential	 because	 both	 expected	 structures	 are	 isomers.	 1H	
NMR	 spectrum	 of	 the	 product	 gave	 important	 information	
about	 characterization	 of	 its	 structure.	 Thus,	 it	 exhibited	 a	
singlet	signal	at		8.16,	which	is	characteristic	for	chemical	shift	
of	 C‐H	 at	 position	 4	 of	 ‐pyrone.	 This	 indicates	 that	 the	
structure	 of	 the	 product	 is	 the	 coumarin	 12	 (Scheme	 4).	
Interestingly,	we	checked	this	result	by	an	alternate	route	when	
we	 carried	 out	 the	 reaction	 of	 salicylaldehyde	 with	
pyranoquinoline	 1,	 in	 acidic	 medium	 to	 retain	 the	 pyrone	
nucleus	 during	 the	 reaction.	 This	 reaction	 was	 constructed	
building	 on	 the	 presence	 of	 4‐hydroxy‐2‐pyrone	 as	 malonyl	
heterocycles,	a	tautomeric	1,3‐dione	form,	which	possesses	an	
active	methylene	site.	Thus,	this	condensation	was	carried	out,	
in	presence	of	 fused	sodium	acetate	 and	glacial	 acetic	 acid,	 to	
give	a	single	product	which	was	found	to	be	different	from	the	
coumarin	derivative	12.	Again	1H	NMR	was	used	to	distinguish	
the	 structure	 of	 the	 product	 in	 which	 a	 methine	 proton	 was	
observed	 in	 the	 normal	 olefinic	 region	 as	 singlet	 at	 δ	 5.68.	
These	results	confirmed	that	the	latter	product	is	the	expected	
structure	 of	 3‐benzylidenepyrano[3,2‐c]quinolinetrione	 13	
(Scheme	4).		
Knoevenagel	 condensation	 of	 the	 ‐keto	 acid	 2	 with	
quinoline‐3‐carbaldehydes	 14a,b	 was	 carried	 out,	 in	 the	
presence	of	 freshly	 fused	sodium	acetate	 in	 glacial	 acetic	 acid	
aiming	to	get	the	acrylic	acid	derivative	15.	Albeit,	the	expected	
acrylic	acid	derivative	15	was	not	isolated,	its	cyclized	products	
3‐(quinolinylmethylene)pyrano[3,2‐c]quinolinetriones	 17a,b	
were	obtained	 (Scheme	5).	The	structure	of	 the	products	was	
established	on	basis	of	their	spectral	and	analytical	data,	which	
showed	 the	 disappearance	 of	 the	 carboxylic	 group	 and	 the	
presence	of	 only	one	hydroxyl	group.	 It	 is	worthwhile	 to	 take	
into	 account	 the	 other	 reasonable	 isomeric	 structure	 16.	
Elemental	microanalyses	and	IR	spectra	did	not	give	significant	
information	to	deduce	which	structure	16	or	17	is	the	product.	
1H	NMR	spectrum	showed	singlet	peak	due	to	chemical	shift	of	
olefinic	 C‐H	 proton	 appeared	 at	 δ	 5.82	 corresponding	 to	
compound	17a,	and	at	δ	5.44	corresponding	to	compound	17b.	
These	 results	confirmed	 the	proposed	 lactonization,	excluding	
formation	 of	 structure	 16.	 There	 is	 no	 explanation	 for	 these	
results	other	than	the	formation	of	Z‐intermediate	15	which	is	
stabilized	 through	 the	 extended	 conjugation	 of	 the	 chain	 HO‐
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C=C‐CH=C‐C=OOH,	in	addition	to	additional	stabilization	comes	
from	 intramolecular	 H‐bonding	 between	 carboxylic	 function	
and	its	neighbouring	hydroxy	and	oxo	functions	(Scheme	5)	
The	 ‐keto	 acid	 2	 was	 subjected	 to	 react	 with	 4‐oxo‐4H‐
chromene‐3‐carbaldehyde	 (18),	 in	 presence	 of	 fused	 sodium	
acetate.	 This	 reaction	 led	 to	 the	 formation	 of	 two	 isolable	
products.	Characterization	of	the	two	products	proved	that	the	
major	 product	 is	 3‐(chromenylmethylene)pyrano[3,2‐
c]quinolinetrione	20.	The	minor	product,	which	was	separated	
from	the	DMF	filtrate	of	crystallization	of	reaction	product,	was	
characterized	 as	 3‐(3‐chromenyl)acryloylquinolinone	 21	
(Scheme	 5).	 The	 structure	 of	 the	 major	 product	
pyranoquinoline	 20	 was	 inferred	 from	 its	 elemental	 and	
spectral	analytical	data.	Microanalysis	for	C,	H,	and	N	elements	
showed	satisfactory	 results	 (within	±	0.4	%)	of	 the	 calculated	
values	 (Table	 1).	 IR	 spectrum	 represented	 strong	 stretching	
band	 at	 	 1748	 correlated	 to	 C=O	 groups	 of	 ‐pyrone,	 and	
1644‐1622	cm‐1	due	to	C=O	groups	of	‐pyrone	and	quinolone.	
1H	 NMR	 spectrum	 showed	 singlet	 signal	 at	 δ	 6.94	 due	 to	
chemical	 shift	 of	 a	 methine	 proton.	 Moreover,	 three	 signals	
were	 also	 observed	 at	 more	 down	 field	 shifts	 at	 δ	 8.17	 as	
doublet	due	to	C5‐H	of	quinoline,	8.37	as	doublet	due	to	C5‐H	of	
‐chromone,	 and	 δ	 8.70	 as	 singlet	 characteristic	 for	 C2‐H	 of	
chromone	 (Table	 2).	 Mass	 spectrum	 revealed	 molecular	 ion	
peak	 at	 m/z	 399,	 which	 is	 in	 agreement	 with	 the	 calculated	
molecular	weight	for	the	formula	(Table	2).	The	minor	product	
acryloylquinoline	 21	 is	 a	 known	 compound	 previously	
prepared	 by	 condensation	 of	 3‐acetyl‐4‐hydroxy‐1‐
methylquinolin‐2(1H)‐one	 and	 4‐oxo‐4H‐chromene‐3‐
carbaldehyde	(18)	[25].	An	authentic	sample	of	the	compound	
21	 was	 compared	 with	 this	 product	 and	 found	 completely	
identical.	This	showed	that	subsequent	to	condensation	to	form	
the	intermediate	19,	partial	decarboxylation	took	place	to	some	
extent	 affording	 the	 acryloylquinoline	 21,	 while	 the	 majority	
cyclized	to	give	the	major	product	pyranoquinoline	20	(Scheme	
5).	
	
4.	Conclusion	
	
4‐Hydroxypyranoquinolinedione	 1	 and	 its	 alkaline	
hydrolysis	product	‐keto	acid	derivative	2	are	useful	synthons	
to	 obtain	 some	 new	 3‐heterocyclic	 substituted	 quinoline‐
2(1H)‐one	derivatives	in	good	yields.	Usage	of	either	compound	
1	or	2	in	condensation	reaction	with	aldehydes	can	lead	to	the	
same	 products	 since	 a	 facile	 lactonization	 of	 the	 ‐keto	 acid	
products	takes	place	in	acid	media.	
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